丹古伊-拜绍草药对通过调节Wnt/β-catenin通路来预防硫酸诱导的大肠炎
Tian Xu1, Wei-Xin Hou1, Sun-Ting Yang1
1Department of Gastroenterology, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing 100730, China.
World journal of gastroenterology
|February 16, 2026
概括
丹古伊-拜绍草药对通过激活Wnt/β-catenin通路,改善肠道屏障功能和调节肠道微生物群来治疗结肠炎. 这种传统的中医药增强了肠道干细胞的活动,并减少了炎症.
科学领域:
- 综合医学是一个整体医学.
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 丹古伊-拜绍草药对是绍耀的核心组成部分,这是治疗大肠炎的传统中医药.
- 大肠炎的治疗仍然是一个重大的临床挑战,需要新的治疗策略.
研究的目的:
- 阐明Danggui-Baishao草药对抗结肠炎作用的潜在机制.
- 研究Wnt/β-catenin信号通路在调解治疗结果中的作用.
主要方法:
- 使用HPLC-Q/TOF-MS进行化学分析.
- 德克斯硫酸盐诱导的小鼠结肠炎模型.
- 多omics分析 (RNA-seq,代谢学,16S rRNA,元基因组学).
- 在体外和分子对接研究中,研究了氏烯.
主要成果:
- 这对草药改善了结肠炎症状,改善了结肠长度,并增强了肠道屏障功能.
- 观察到Wnt/β-catenin通路的激活和肠干细胞标记物的上调.
- 肠道微生物群调节得到证实,益生菌增加和病原体减少.
结论:
- 丹古伊-拜绍草药对在减少结肠炎症和恢复肠道屏障完整性方面表现出显著的有效性.
- Wnt/β-catenin通路的激活是草本对抗结肠炎作用的关键机制.
相关概念视频
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.6K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.6K
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
1.4K
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
1.4K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
2.4K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
2.4K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.7K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.7K
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
864
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
864
Peptic Ulcer Disease IV: Management
821
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
821


